메뉴 건너뛰기




Volumn 19, Issue 2, 1996, Pages 241-273

Prodrugs of anticancer agents

Author keywords

Acid phosphatase; Antibody directed enzyme prodrug therapy (ADEPT); Anticancer agent; Azoreductase; CNS delivery; Hypoxia selectivity; N Oxide; Nitroaromatic; Nitroimidazole; Plasmin; Prodrug; Quinone; Taxol; Tumor targeting; Glucuronidase; Glutamyl transpeptidase

Indexed keywords

AGENTS; ANTIGENS; CELLS; DNA; DRUG THERAPY; ENZYMES; ONCOLOGY; PHARMACOKINETICS; SOLUBILITY; TISSUE; TOXICITY; TRANSPORT PROPERTIES;

EID: 0343337640     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00109-K     Document Type: Review
Times cited : (113)

References (235)
  • 4
    • 0001199533 scopus 로고
    • Chemical aspects of selective toxicity
    • Albert, A. (1958) Chemical aspects of selective toxicity. Nature 182, 421-423
    • (1958) Nature , vol.182 , pp. 421-423
    • Albert, A.1
  • 6
    • 0342879280 scopus 로고
    • Prodrugs in cancer chemotherapy
    • H. Bundgaard (Ed.), Elsevier, Amsterdam
    • Connors, T.A. (1985) Prodrugs in cancer chemotherapy. In: H. Bundgaard (Ed.), Design of Prodrugs, Elsevier, Amsterdam, pp. 291-316.
    • (1985) Design of Prodrugs , pp. 291-316
    • Connors, T.A.1
  • 8
    • 21844523601 scopus 로고
    • Prodrugs of analogs of nucleic acid components
    • Alexander, P. and Holy, A. (1994) Prodrugs of analogs of nucleic acid components. Coll. Czech. Chem. Commun. 59, 2127-2165.
    • (1994) Coll. Czech. Chem. Commun. , vol.59 , pp. 2127-2165
    • Alexander, P.1    Holy, A.2
  • 10
    • 0027984188 scopus 로고
    • Future of prodrugs in antiviral therapy
    • Hasegawa, T. and Kawaguchi, T. (1994) Future of prodrugs in antiviral therapy. Clin. Pharmacokinet. 27, 331-336.
    • (1994) Clin. Pharmacokinet. , vol.27 , pp. 331-336
    • Hasegawa, T.1    Kawaguchi, T.2
  • 11
    • 0027268101 scopus 로고
    • Acyclovir prodrugs: The road to valaciclovir
    • Beauchamp, L.M. and Krenitsky, T.A. (1993) Acyclovir prodrugs: the road to valaciclovir. Drugs Future 18, 619-628.
    • (1993) Drugs Future , vol.18 , pp. 619-628
    • Beauchamp, L.M.1    Krenitsky, T.A.2
  • 12
    • 0027131363 scopus 로고
    • Penciclovir: A review of its spectrum of activity, selectivity, and cross-resistance pattern
    • Boyd, M.R., Safrin, S. and Kern, E.R. (1993) Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem. Chemother. 4, 3-11.
    • (1993) Antiviral Chem. Chemother. , vol.4 , pp. 3-11
    • Boyd, M.R.1    Safrin, S.2    Kern, E.R.3
  • 15
    • 0345678344 scopus 로고
    • Design of antitumor prodrugs: Substrates for antibody targeted enzymes
    • Jungheim, L.N. and Shepard, T.A. (1994) Design of antitumor prodrugs: substrates for antibody targeted enzymes. Chem. Rev. 94, 1553-1566.
    • (1994) Chem. Rev. , vol.94 , pp. 1553-1566
    • Jungheim, L.N.1    Shepard, T.A.2
  • 16
    • 0027942024 scopus 로고
    • Antibody-directed enzyme prodrug therapy
    • Bagshawe, K.D. (1994) Antibody-directed enzyme prodrug therapy. Clin. Parmacokinet. 27, 368-376.
    • (1994) Clin. Parmacokinet. , vol.27 , pp. 368-376
    • Bagshawe, K.D.1
  • 17
    • 0028219716 scopus 로고
    • Antibody-directed enzyme prodrug therapy (Adept)
    • Bagshawe, K.D. (1994) Antibody-directed enzyme prodrug therapy (Adept). J. Control. Release 28, 187-193.
    • (1994) J. Control. Release , vol.28 , pp. 187-193
    • Bagshawe, K.D.1
  • 18
    • 0028264106 scopus 로고
    • Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors
    • Huber, B.E., Richards, C.A. and Austin, E.A. (1994) Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors. Ann. N.Y. Acad. Sci. 7, 104-114.
    • (1994) Ann. N.Y. Acad. Sci. , vol.7 , pp. 104-114
    • Huber, B.E.1    Richards, C.A.2    Austin, E.A.3
  • 19
    • 0028091914 scopus 로고
    • Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates
    • Wallace, P.M. and Senter, P.D. (1994) Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates. Methods Find. Exp. Clin. Pharmacol. 16, 505-512.
    • (1994) Methods Find. Exp. Clin. Pharmacol. , vol.16 , pp. 505-512
    • Wallace, P.M.1    Senter, P.D.2
  • 20
    • 0028455028 scopus 로고
    • Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugates
    • Huennekens, F.M. (1994) Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates. Trends Biotechnol. 2, 234-239.
    • (1994) Trends Biotechnol. , vol.2 , pp. 234-239
    • Huennekens, F.M.1
  • 21
    • 0027355456 scopus 로고
    • Antibody-directed enzyme prodrug therapy (ADEPT)
    • Bagshawe, K.D. (1993) Antibody-directed enzyme prodrug therapy (ADEPT). Adv. Pharmacol. 24, 99-121.
    • (1993) Adv. Pharmacol. , vol.24 , pp. 99-121
    • Bagshawe, K.D.1
  • 22
    • 0027182862 scopus 로고
    • The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT)
    • Knox, R.J., Friedlos, F. and Boland, M.P. (1993) The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). Cancer Metastasis Rev. 12, 195-212.
    • (1993) Cancer Metastasis Rev. , vol.12 , pp. 195-212
    • Knox, R.J.1    Friedlos, F.2    Boland, M.P.3
  • 23
    • 0342444737 scopus 로고
    • Molecular and functional characterization of a fusion protein suited for tumour specific prodrug activation
    • Epenetos, A.A. (Ed.), Chapman and Hall, London
    • Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H.H., Schuermann, M. and Seemann, G. (1993) Molecular and functional characterization of a fusion protein suited for tumour specific prodrug activation. In: Epenetos, A.A. (Ed.), Monoclonal Antibodies 2: Applications in Clinical Oncology, Chapman and Hall, London, pp. 205-217.
    • (1993) Monoclonal Antibodies 2: Applications in Clinical Oncology , pp. 205-217
    • Bosslet, K.1    Czech, J.2    Lorenz, P.3    Sedlacek, H.H.4    Schuermann, M.5    Seemann, G.6
  • 24
    • 0342444735 scopus 로고
    • Monoclonal antibody enzyme conjugates for prodrug activation: Therapeutic effects and mechanistic considerations
    • Epenetos, A.A. (Ed.), Chapman and Hall, London
    • Senter, P.D. and Wallace, P.M. (1993) Monoclonal antibody enzyme conjugates for prodrug activation: therapeutic effects and mechanistic considerations. In: Epenetos, A.A. (Ed.), Monoclonal Antibodies 2: Applications in Clinical Oncology, Chapman and Hall, London, pp. 453-461.
    • (1993) Monoclonal Antibodies 2: Applications in Clinical Oncology , pp. 453-461
    • Senter, P.D.1    Wallace, P.M.2
  • 26
    • 0343314235 scopus 로고
    • Drug targeting with monoclonal antibodies
    • Blakey, D.C. (1992) Drug targeting with monoclonal antibodies. Rev. Oncol. 5, 91-97.
    • (1992) Rev. Oncol. , vol.5 , pp. 91-97
    • Blakey, D.C.1
  • 28
    • 0029145803 scopus 로고
    • Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs
    • Springer, C.J. and Niculescu-Duvaz, I. (1995) Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs. Anticancer Drug Des. 10, 361-372.
    • (1995) Anticancer Drug Des. , vol.10 , pp. 361-372
    • Springer, C.J.1    Niculescu-Duvaz, I.2
  • 30
    • 0025174052 scopus 로고
    • Activation of prodrugs by antibody-enzyme conjugates: A new approach to cancer therapy
    • Senter, P.D. (1990) Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy. FASEB J. 4, 188-193.
    • (1990) FASEB J. , vol.4 , pp. 188-193
    • Senter, P.D.1
  • 31
    • 0025071928 scopus 로고
    • Antitumor effects of antibody enzyme conjugates in combination with prodrugs
    • Senter, P.D. (1990) Antitumor effects of antibody enzyme conjugates in combination with prodrugs. Front. Radiat. Ther. Oncol. 24, 132-141.
    • (1990) Front. Radiat. Ther. Oncol. , vol.24 , pp. 132-141
    • Senter, P.D.1
  • 32
    • 0023619243 scopus 로고
    • Antibody directed enzyme revive anti-cancer prodrugs concept
    • Bagshawe, K.D. (1987) Antibody directed enzyme revive anti-cancer prodrugs concept. Br. J. Cancer 56, 531-532.
    • (1987) Br. J. Cancer , vol.56 , pp. 531-532
    • Bagshawe, K.D.1
  • 33
    • 0027942213 scopus 로고
    • Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185
    • Eccles, S.A., Court, W.J., Box, G.A., Dean, C.J., Melton, R.G. and Springer, C.J. (1994) Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Cancer Res. 54, 5171-5177.
    • (1994) Cancer Res. , vol.54 , pp. 5171-5177
    • Eccles, S.A.1    Court, W.J.2    Box, G.A.3    Dean, C.J.4    Melton, R.G.5    Springer, C.J.6
  • 34
    • 0028122014 scopus 로고
    • Novel prodrugs of alkylating agents derived from 2-fluoro-and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapy
    • Springer, C.J., Niculescu-Duvaz, I. and Pedley, B. (1994) Novel prodrugs of alkylating agents derived from 2-fluoro-and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapy. J. Med. Chem. 37, 2361-2370.
    • (1994) J. Med. Chem. , vol.37 , pp. 2361-2370
    • Springer, C.J.1    Niculescu-Duvaz, I.2    Pedley, B.3
  • 35
    • 0028014458 scopus 로고
    • Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy
    • Sharma, S.K., Bagshawe, K.D., Burke, P.J., Boden, J.A., Rogers, G.T., Springer, C.J., Melton, R.G. and Sherwood, R.F. (1994) Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapy. Cancer 73 (Suppl. 3), 1114-1120.
    • (1994) Cancer , vol.73 , Issue.SUPPL. 3 , pp. 1114-1120
    • Sharma, S.K.1    Bagshawe, K.D.2    Burke, P.J.3    Boden, J.A.4    Rogers, G.T.5    Springer, C.J.6    Melton, R.G.7    Sherwood, R.F.8
  • 37
    • 0027538972 scopus 로고
    • Identification of prodrug, active drug, and metabolites in an ADEPT clinical study
    • Springer, C.J., Poon, G.K., Sharma, S.K. and Bagshawe, K.D. (1993) Identification of prodrug, active drug, and metabolites in an ADEPT clinical study. Cell Biophys. 2, 9-26.
    • (1993) Cell Biophys. , vol.2 , pp. 9-26
    • Springer, C.J.1    Poon, G.K.2    Sharma, S.K.3    Bagshawe, K.D.4
  • 40
    • 0026335039 scopus 로고
    • Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT)
    • Springer, C.J., Antoniw, P., Bagshawe, K.D. and Wilman, D.E.V. (1991) Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT). Anti-Cancer Drug Des. 6, 467-479.
    • (1991) Anti-cancer Drug Des. , vol.6 , pp. 467-479
    • Springer, C.J.1    Antoniw, P.2    Bagshawe, K.D.3    Wilman, D.E.V.4
  • 45
    • 0025189891 scopus 로고
    • Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2
    • Springer, C.J., Antoniw, P., Bagshawe, K.D., Searle, F., Bisset, G.M.F. and Jarman, M. (1990) Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. J. Med. Chem. 33, 677-681.
    • (1990) J. Med. Chem. , vol.33 , pp. 677-681
    • Springer, C.J.1    Antoniw, P.2    Bagshawe, K.D.3    Searle, F.4    Bisset, G.M.F.5    Jarman, M.6
  • 46
    • 0343749979 scopus 로고
    • Phosphatase activated water-soluble prodrugs of taxol
    • Vyas, D.M. (1994) Phosphatase activated water-soluble prodrugs of taxol. Abstr. Pap. Am. Chem. Soc. Med. Abstr. No. 142.
    • (1994) Abstr. Pap. Am. Chem. Soc. Med. Abstr. , vol.142
    • Vyas, D.M.1
  • 47
    • 0026577584 scopus 로고
    • Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphates for specific activation of the prodrug etoposide phosphate
    • Haisma, H.J., Boven, E., Van Muijen, M., De Vries, R. and Pinedo, H.M. (1992) Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphates for specific activation of the prodrug etoposide phosphate. Cancer Immunol. Immunother. 34, 343-348.
    • (1992) Cancer Immunol. Immunother. , vol.34 , pp. 343-348
    • Haisma, H.J.1    Boven, E.2    Van Muijen, M.3    De Vries, R.4    Pinedo, H.M.5
  • 48
    • 0026212613 scopus 로고
    • In vitro, in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate
    • Wallace, P.M. and Senter, P.D. (1991) In vitro, in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate. Bioconj. Chem. 2, 349-352.
    • (1991) Bioconj. Chem. , vol.2 , pp. 349-352
    • Wallace, P.M.1    Senter, P.D.2
  • 49
    • 0025186181 scopus 로고
    • Specific activation of the prodrug mitomycin phosphate by a bispecific anti-cd30/anti-alkaline phosphatase monoclonal antibody
    • Sahin, U., Hartmann, F., Senter, P., Pohl, C., Engert, A., Diehl, V. and Pfreundschuh, M. (1990) Specific activation of the prodrug mitomycin phosphate by a bispecific anti-cd30/anti-alkaline phosphatase monoclonal antibody. Cancer Res. 50, 6944-6948.
    • (1990) Cancer Res. , vol.50 , pp. 6944-6948
    • Sahin, U.1    Hartmann, F.2    Senter, P.3    Pohl, C.4    Engert, A.5    Diehl, V.6    Pfreundschuh, M.7
  • 50
    • 0024446208 scopus 로고
    • Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates
    • Senter, P.D., Schreiber, G.J., Hirschberg, D.L., Ashe, S.A., Hellstrom, K.E. and Hellstrom, I. (1989) Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates. Cancer Res. 49, 5789-5792.
    • (1989) Cancer Res. , vol.49 , pp. 5789-5792
    • Senter, P.D.1    Schreiber, G.J.2    Hirschberg, D.L.3    Ashe, S.A.4    Hellstrom, K.E.5    Hellstrom, I.6
  • 52
    • 0028718114 scopus 로고
    • Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer
    • Haisma, H.J., Van Muijen, M., Pinedo, H.M. and Boven, E. (1994) Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer. Cell Biophys. 24/25, 185-192.
    • (1994) Cell Biophys. , vol.24-25 , pp. 185-192
    • Haisma, H.J.1    Van Muijen, M.2    Pinedo, H.M.3    Boven, E.4
  • 53
    • 0028348376 scopus 로고
    • Tumor selective prodrug activation by fusion protein-mediated catalysis
    • Bosslet, K., Czech, J. and Hoffmann, D. (1994) Tumor selective prodrug activation by fusion protein-mediated catalysis. Cancer Res. 54, 2151-2159.
    • (1994) Cancer Res. , vol.54 , pp. 2151-2159
    • Bosslet, K.1    Czech, J.2    Hoffmann, D.3
  • 55
    • 0026794283 scopus 로고
    • Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy
    • Wang, S.-M., Chern, J.-W., Yeh, M.-Y., Ng, J.C., Tung, E. and Roffler, S.R. (1992) Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res. 52, 4484-4491.
    • (1992) Cancer Res. , vol.52 , pp. 4484-4491
    • Wang, S.-M.1    Chern, J.-W.2    Yeh, M.-Y.3    Ng, J.C.4    Tung, E.5    Roffler, S.R.6
  • 56
    • 0026569992 scopus 로고
    • Molecular and functional characterisation of a fusion protein suited for tumor specific prodrug activation
    • Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H.H., Schuermann, M. and Seemann, G. (1992) Molecular and functional characterisation of a fusion protein suited for tumor specific prodrug activation. Br. J. Cancer 65, 234-238.
    • (1992) Br. J. Cancer , vol.65 , pp. 234-238
    • Bosslet, K.1    Czech, J.2    Lorenz, P.3    Sedlacek, H.H.4    Schuermann, M.5    Seemann, G.6
  • 57
    • 0026802983 scopus 로고
    • A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer
    • Haisma, H.J., Boven, E., Van Muijen, M., De Jong, J., Van der Vijgh, W.J.F. and Pined H.M. (1992) A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer. Br. J. Cancer 66, 474-478.
    • (1992) Br. J. Cancer , vol.66 , pp. 474-478
    • Haisma, H.J.1    Boven, E.2    Van Muijen, M.3    De Jong, J.4    Van Der Vijgh, W.J.F.5    Pined, H.M.6
  • 58
    • 0025936081 scopus 로고
    • Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate
    • Roffler, S. (1991) Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate. Biochem. Pharmacol. 42, 2062-2065.
    • (1991) Biochem. Pharmacol. , vol.42 , pp. 2062-2065
    • Roffler, S.1
  • 60
    • 0028425474 scopus 로고
    • Synthesis and characterization of monoclonal antibody-β-lactamase conjugates
    • Svensson, H.P., Wallace, P.M. and Senter, P.D. (1994) Synthesis and characterization of monoclonal antibody-β-lactamase conjugates. Bioconj. Chem. 5, 262-267.
    • (1994) Bioconj. Chem. , vol.5 , pp. 262-267
    • Svensson, H.P.1    Wallace, P.M.2    Senter, P.D.3
  • 61
    • 0000814098 scopus 로고
    • Synthesis of a cephalosporin-doxorubicin antitumor prodrug: A substrate for an antibody-targeted enzyme
    • Jungheim, L.N., Shepherd, T.A. and King, J.K. (1993) Synthesis of a cephalosporin-doxorubicin antitumor prodrug: a substrate for an antibody-targeted enzyme. Heterocycles 35, 339-347.
    • (1993) Heterocycles , vol.35 , pp. 339-347
    • Jungheim, L.N.1    Shepherd, T.A.2    King, J.K.3
  • 62
    • 0027220125 scopus 로고
    • Site-specific prodrug activation by antibody-β-lactamase conjugates: Regression and long-term growth inhibition of human colon carcinoma xenograft models
    • Meyer, D.L., Jungheim, L.N., Law, K.L., Mikolajczyk, S.D., Shepherd, T.A., Mackensen, D.G., Briggs, S.L. and Starling, J.J. (1993) Site-specific prodrug activation by antibody-β-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models. Cancer Res. 53, 3956-3963.
    • (1993) Cancer Res. , vol.53 , pp. 3956-3963
    • Meyer, D.L.1    Jungheim, L.N.2    Law, K.L.3    Mikolajczyk, S.D.4    Shepherd, T.A.5    Mackensen, D.G.6    Briggs, S.L.7    Starling, J.J.8
  • 63
    • 0027157591 scopus 로고
    • Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to β-lactamase
    • Goshorn, S.C., Svensson, H.P., Kerr, D.E., Somerville, J.E., Senter, P.D and Fell, H.P. (1993) Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to β-lactamase. Cancer Res. 53, 2123-2127.
    • (1993) Cancer Res. , vol.53 , pp. 2123-2127
    • Goshorn, S.C.1    Svensson, H.P.2    Kerr, D.E.3    Somerville, J.E.4    Senter, P.D.5    Fell, H.P.6
  • 64
    • 0027235973 scopus 로고
    • Design and sythesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase
    • Hanessian, S. and Wang, J. (1993) Design and sythesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase. Can. J. Chem. 71, 896-906.
    • (1993) Can. J. Chem. , vol.71 , pp. 896-906
    • Hanessian, S.1    Wang, J.2
  • 65
    • 0027655158 scopus 로고
    • Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-β-lactamase conjugates
    • Vrudhula, V.M., Svensson, H.P., Kennedy, K.A., Senter, P.D. and Wallace, P.M. (1993) Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-β-lactamase conjugates. Bioconj. Chem. 4, 334-340.
    • (1993) Bioconj. Chem. , vol.4 , pp. 334-340
    • Vrudhula, V.M.1    Svensson, H.P.2    Kennedy, K.A.3    Senter, P.D.4    Wallace, P.M.5
  • 66
    • 0026826545 scopus 로고
    • Monoclonal antibody-β-lactamase conjugates for the activities of a cephalosporin mustard prodrug
    • Svensson, H.P., Kadow, J.F., Vrudhula, V.M., Wallace, P.M. and Senter, P.D. (1992) Monoclonal antibody-β-lactamase conjugates for the activities of a cephalosporin mustard prodrug. Bioconj. Chem. 3, 176-181.
    • (1992) Bioconj. Chem. , vol.3 , pp. 176-181
    • Svensson, H.P.1    Kadow, J.F.2    Vrudhula, V.M.3    Wallace, P.M.4    Senter, P.D.5
  • 68
    • 0026562808 scopus 로고
    • Synthesis of acylhydrazido-substituted cephems, design of cephalosporin-vinca alkaloid prodrugs: Substrates for an antibody-targeted enzyme
    • Jungheim, L.N., Shepherd, T.A. and Meyer, D.L. (1992) Synthesis of acylhydrazido-substituted cephems, design of cephalosporin-vinca alkaloid prodrugs: substrates for an antibody-targeted enzyme. J. Org. Chem. 57, 2334-2340.
    • (1992) J. Org. Chem. , vol.57 , pp. 2334-2340
    • Jungheim, L.N.1    Shepherd, T.A.2    Meyer, D.L.3
  • 69
    • 0026487592 scopus 로고
    • Preparation and characterization of a β-lactamase-fab′ conjugate for the site specific activation of oncolytic agents
    • Meyer, D.L., Jungheim, L.N., Mikolajczyk, S.D., Shepherd, T.A., Starling. J.J. and Ahlem, C.N. (1992) Preparation and characterization of a β-lactamase-fab′ conjugate for the site specific activation of oncolytic agents. Bioconj. Chem. 3, 42-48.
    • (1992) Bioconj. Chem. , vol.3 , pp. 42-48
    • Meyer, D.L.1    Jungheim, L.N.2    Mikolajczyk, S.D.3    Shepherd, T.A.4    Starling, J.J.5    Ahlem, C.N.6
  • 70
    • 0025864963 scopus 로고
    • A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer
    • Shepherd, T.A., Jungheim, L.N., Meyer, D.L. and Starling, J.J. (1991) A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer. Bioorg. Med. Chem. Lett. 1, 21-26.
    • (1991) Bioorg. Med. Chem. Lett. , vol.1 , pp. 21-26
    • Shepherd, T.A.1    Jungheim, L.N.2    Meyer, D.L.3    Starling, J.J.4
  • 72
    • 0011489533 scopus 로고
    • Activation of methotrexate prodrugs by enzyme/monoclonal antibody conjugates
    • Vitols, K.S., Haenseler, E., Montejano, Y., Baer, T. and Huennekens, F.M. (1992) Activation of methotrexate prodrugs by enzyme/monoclonal antibody conjugates. Pteridines 3, 125-126.
    • (1992) Pteridines , vol.3 , pp. 125-126
    • Vitols, K.S.1    Haenseler, E.2    Montejano, Y.3    Baer, T.4    Huennekens, F.M.5
  • 76
    • 0028090161 scopus 로고
    • Self-immolative prodrugs: Candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme
    • Mauger, A.B., Burke, P.J., Somani, H.H., Friedlos, F. and Knox, R.J. (1994) Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme. J. Med. Chem. 37, 3452-3458.
    • (1994) J. Med. Chem. , vol.37 , pp. 3452-3458
    • Mauger, A.B.1    Burke, P.J.2    Somani, H.H.3    Friedlos, F.4    Knox, R.J.5
  • 77
    • 0026670255 scopus 로고
    • N-(4′-hydroxyphenylacetyl) palytoxin: A palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate
    • Bignami, G.S., Senter, P.D., Grothaus. P.G., Fischer, K.J., Humphreys, T. and Wallace, P.M. (1992) N-(4′-hydroxyphenylacetyl) palytoxin: a palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate. Cancer Res. 52, 5759-5764.
    • (1992) Cancer Res. , vol.52 , pp. 5759-5764
    • Bignami, G.S.1    Senter, P.D.2    Grothaus, P.G.3    Fischer, K.J.4    Humphreys, T.5    Wallace, P.M.6
  • 78
    • 0025352171 scopus 로고
    • Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide
    • Kerr, D.E., Senter, P.D., Burnett, W.V., Hirschberg, D.L., Hellstrom, I and Hellstrom, K.E. (1990) Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide. Cancer Immunol. Immunother. 31, 202-206.
    • (1990) Cancer Immunol. Immunother. , vol.31 , pp. 202-206
    • Kerr, D.E.1    Senter, P.D.2    Burnett, W.V.3    Hirschberg, D.L.4    Hellstrom, I.5    Hellstrom, K.E.6
  • 79
    • 0027537670 scopus 로고
    • Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate
    • Vrudhula, V.M., Senter, P.D., Fischer, K.J. and Wallace, P.M. (1993) Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate. J. Med. Chem. 36, 919-923.
    • (1993) J. Med. Chem. , vol.36 , pp. 919-923
    • Vrudhula, V.M.1    Senter, P.D.2    Fischer, K.J.3    Wallace, P.M.4
  • 81
    • 0024573728 scopus 로고
    • A new strategy for the generation of catalytic antibodies
    • Shokat, K.M., Leumann, C.J., Sugasawara, R. and Schultz, P.G. (1989) A new strategy for the generation of catalytic antibodies. Nature 338, 269-274.
    • (1989) Nature , vol.338 , pp. 269-274
    • Shokat, K.M.1    Leumann, C.J.2    Sugasawara, R.3    Schultz, P.G.4
  • 82
    • 0023203173 scopus 로고
    • Biodistribution of antibodies after intra-peritoneal and intravenous injection and effect of carbohydrate modification
    • Mattes M.J. (1987) Biodistribution of antibodies after intra-peritoneal and intravenous injection and effect of carbohydrate modification. J. Natl. Cancer Inst. 79, 855-863.
    • (1987) J. Natl. Cancer Inst. , vol.79 , pp. 855-863
    • Mattes, M.J.1
  • 83
    • 0025373638 scopus 로고
    • Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model
    • Sharma, S.K., Bagshawe, K.D. Burke, P.J., Boden, R.W. and Rogers, G.T. (1990) Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model. Br. J. Cancer 61 659-62.
    • (1990) Br. J. Cancer , vol.61 , pp. 659-662
    • Sharma, S.K.1    Bagshawe, K.D.2    Burke, P.J.3    Boden, R.W.4    Rogers, G.T.5
  • 85
    • 0027288316 scopus 로고
    • SR 4233 (Tirapazamine): A new anticancer drug exploiting hypoxia in solid tumours
    • Brown, J.M. (1993) SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer 67, 1163-1170.
    • (1993) Br. J. Cancer , vol.67 , pp. 1163-1170
    • Brown, J.M.1
  • 86
    • 0023082510 scopus 로고
    • Tumor hypoxia: Its impact on cancer therapy
    • Moulder, J.E. and Rockwell, S. (1987). Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev. 5, 313-341.
    • (1987) Cancer Metastasis Rev. , vol.5 , pp. 313-341
    • Moulder, J.E.1    Rockwell, S.2
  • 89
    • 0025807618 scopus 로고
    • Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized oxygen tension measurements
    • Vaupel, P., Schlenger, K., Knoop, C. and Hockel, M. (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized oxygen tension measurements. Cancer Res. 51 3316-3322.
    • (1991) Cancer Res. , vol.51 , pp. 3316-3322
    • Vaupel, P.1    Schlenger, K.2    Knoop, C.3    Hockel, M.4
  • 90
    • 0023555121 scopus 로고
    • Hypoxic cell as specified drug targets for chemotherapy
    • Kennedy, K.A. (1987) Hypoxic cell as specified drug targets for chemotherapy. Anticancer Drug Des. 2, 181-194.
    • (1987) Anticancer Drug Des. , vol.2 , pp. 181-194
    • Kennedy, K.A.1
  • 91
    • 0023902264 scopus 로고
    • Therapeutic attack of hypoxic cells of solid tumors: Presidential address
    • Sartorelli, A.C. (1988). Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res. 48, 775-778.
    • (1988) Cancer Res. , vol.48 , pp. 775-778
    • Sartorelli, A.C.1
  • 92
    • 0019491278 scopus 로고
    • Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions
    • Tannock, I. and Guttman, P. (1981) Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br. J. Cancer 42, 245-248.
    • (1981) Br. J. Cancer , vol.42 , pp. 245-248
    • Tannock, I.1    Guttman, P.2
  • 93
    • 0015451983 scopus 로고
    • Potential bioreductive alkylating agents. 1. Benzoquinone derivatives
    • Lin, A.J., Cosby, L.A., Shansky, C.W. and Sartorelli, A.C. (1972) Potential bioreductive alkylating agents. 1. Benzoquinone derivatives. J. Med. Chem. 15, 1247-1252.
    • (1972) J. Med. Chem. , vol.15 , pp. 1247-1252
    • Lin, A.J.1    Cosby, L.A.2    Shansky, C.W.3    Sartorelli, A.C.4
  • 94
    • 0001918114 scopus 로고
    • Hypoxia-selective cytotoxins
    • Foye, W.O. (Ed.), American Chemical Society, Washington, DC
    • Denny, W.A. (1995) Hypoxia-selective cytotoxins. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 483-497.
    • (1995) Cancer Chemotherapeutic Agents , pp. 483-497
    • Denny, W.A.1
  • 95
    • 0023892307 scopus 로고
    • The metabolic activation of nitroheterocyclic therapeutic agents
    • Kedderis, G.L. and Miwa, G.T. (1988) The metabolic activation of nitroheterocyclic therapeutic agents. Drug Metab. Rev. 19, 33-62.
    • (1988) Drug Metab. Rev. , vol.19 , pp. 33-62
    • Kedderis, G.L.1    Miwa, G.T.2
  • 97
    • 0021362088 scopus 로고
    • Relationships between functionality and genetic toxicology of selected DNA-damaging agents
    • Brendel, M. and Ruhland, A. (1984) Relationships between functionality and genetic toxicology of selected DNA-damaging agents. Mutat. Res. 133, 51-85.
    • (1984) Mutat. Res. , vol.133 , pp. 51-85
    • Brendel, M.1    Ruhland, A.2
  • 98
    • 0025776614 scopus 로고
    • Targeting radiosensitizers to DNA by attachment of an intercalating group: Nitroimidazole-linked phenanthridines
    • Cowan, D.M.S., Panicucci, R., McClelland, R.A. and Rauth, A.M. (1991) Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines. Radiat Res. 127, 81-89.
    • (1991) Radiat Res. , vol.127 , pp. 81-89
    • Cowan, D.M.S.1    Panicucci, R.2    McClelland, R.A.3    Rauth, A.M.4
  • 100
    • 0023228137 scopus 로고
    • Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole aziridines RSU-1069 and RSU 1131
    • O'Neill, P., McNeil, S.S. and Jenkins, T.C. (1987) Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole aziridines RSU-1069 and RSU 1131. Biochem. Pharmacol. 36, 1787-1792.
    • (1987) Biochem. Pharmacol. , vol.36 , pp. 1787-1792
    • O'Neill, P.1    McNeil, S.S.2    Jenkins, T.C.3
  • 101
    • 0021260987 scopus 로고
    • Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo
    • Adams, G.E., Ahmed, I., Sheldon, P.W. and Stratford, I.J. (1984) Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. Br. J. Cancer 40, 571-577.
    • (1984) Br. J. Cancer , vol.40 , pp. 571-577
    • Adams, G.E.1    Ahmed, I.2    Sheldon, P.W.3    Stratford, I.J.4
  • 102
    • 0025117882 scopus 로고
    • Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins
    • Naylor, M.A., Stephens, M.A., Cole, S., Threadgill, M.D., Stratford, I.J., O'Neill, P., Fielden, E.M. and Adams, G.E. (1990) Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins. J. Med. Chem. 33, 2603-2610.
    • (1990) J. Med. Chem. , vol.33 , pp. 2603-2610
    • Naylor, M.A.1    Stephens, M.A.2    Cole, S.3    Threadgill, M.D.4    Stratford, I.J.5    O'Neill, P.6    Fielden, E.M.7    Adams, G.E.8
  • 103
    • 0022486242 scopus 로고
    • Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069
    • Hill, R.P., Guylas, S. and Whitmore, G.F. (1986) Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069. Br. J. Cancer 53, 743-751.
    • (1986) Br. J. Cancer , vol.53 , pp. 743-751
    • Hill, R.P.1    Guylas, S.2    Whitmore, G.F.3
  • 105
    • 0025915256 scopus 로고
    • Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins
    • Threadgill, M.D., Webb, P., O'Neill, P., Naylor, M.A., Stephens, M.A., Stratford, I.J., Cole, S., Adams, G.E. and Fieldon, E.M. (1991) Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins. J. Med. Chem. 34, 2112-2120.
    • (1991) J. Med. Chem. , vol.34 , pp. 2112-2120
    • Threadgill, M.D.1    Webb, P.2    O'Neill, P.3    Naylor, M.A.4    Stephens, M.A.5    Stratford, I.J.6    Cole, S.7    Adams, G.E.8    Fieldon, E.M.9
  • 106
    • 0025023154 scopus 로고
    • Synthesis and evaluation of α-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of α-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RS-U-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins
    • Jenkins, T.C., Naylor, M.A., O'Neill, P., Threadgill, M.D., Cole, S., Stratford, I.J., Adams, G.E., Fielden, E.M., Suto, M.J. and Stier, M.A. (1990) Synthesis and evaluation of α-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of α-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RS-U-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins. J. Med. Chem. 33, 2603-2610.
    • (1990) J. Med. Chem. , vol.33 , pp. 2603-2610
    • Jenkins, T.C.1    Naylor, M.A.2    O'Neill, P.3    Threadgill, M.D.4    Cole, S.5    Stratford, I.J.6    Adams, G.E.7    Fielden, E.M.8    Suto, M.J.9    Stier, M.A.10
  • 107
    • 0025826381 scopus 로고
    • Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice
    • Cole, S., Stratford, I.J., Bowler, J., Nolan, J., Wright, E.J., Lorimore, S.A. and Adams, G.E. (1991) Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice. Int. J. Radiat. Oncol. Biol. Phys. 21, 387-395.
    • (1991) Int. J. Radiat. Oncol. Biol. Phys. , vol.21 , pp. 387-395
    • Cole, S.1    Stratford, I.J.2    Bowler, J.3    Nolan, J.4    Wright, E.J.5    Lorimore, S.A.6    Adams, G.E.7
  • 108
    • 0026072447 scopus 로고
    • Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed function hypoxic cell sensitizer/cytotoxin α-(1-aziridinomethyl)-2-nitro-1H-imadazole-1 -ethanol (RSU 1069)
    • Binger, M. and Workman, P.J. (1991) Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed function hypoxic cell sensitizer/cytotoxin α-(1-aziridinomethyl)-2-nitro-1H-imadazole-1 -ethanol (RSU 1069). Cancer Chemother. Pharmacol. 29, 37-47.
    • (1991) Cancer Chemother. Pharmacol. , vol.29 , pp. 37-47
    • Binger, M.1    Workman, P.J.2
  • 109
    • 0027290844 scopus 로고
    • Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: With particular reference to in vivo methods of evaluation
    • Bremner, J.CM. (1993) Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation. Cancer Metastasis Rev. 12, 177-193.
    • (1993) Cancer Metastasis Rev. , vol.12 , pp. 177-193
    • Bremner, J.C.M.1
  • 112
    • 0023218399 scopus 로고
    • Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
    • Sebolt, J.S., Scavone, S.V., Pinter, C.D., Hamelehle, K.I., von Hoff, D.D. and Jackson, R.C. (1987) Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro. Cancer Res. 47, 4299-4304.
    • (1987) Cancer Res. , vol.47 , pp. 4299-4304
    • Sebolt, J.S.1    Scavone, S.V.2    Pinter, C.D.3    Hamelehle, K.I.4    Von Hoff, D.D.5    Jackson, R.C.6
  • 114
    • 0024491246 scopus 로고
    • Hypoxia-selecive antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine
    • Wilson, W.R., Anderson, R.F. and Denny, W.A. (1989) Hypoxia-selecive antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine. J. Med. Chem. 32, 23-30.
    • (1989) J. Med. Chem. , vol.32 , pp. 23-30
    • Wilson, W.R.1    Anderson, R.F.2    Denny, W.A.3
  • 116
    • 0024529829 scopus 로고
    • Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives
    • Wilson, W.R., Thompson, L.H., Anderson, R.F. and Denny, W.A. (1989) Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. J. Med. Chem. 32, 31-38.
    • (1989) J. Med. Chem. , vol.32 , pp. 31-38
    • Wilson, W.R.1    Thompson, L.H.2    Anderson, R.F.3    Denny, W.A.4
  • 117
    • 37049070925 scopus 로고
    • Effect of reduction potential, on the rate of reduction of nitroacridines by xanthine oxidase and by dihydroflavin mononucleotide
    • OConnor, C.J., Denny, W.A., McLennan, D.J., Sutton, B.M. and Wilson, W.R. (1991) Effect of reduction potential, on the rate of reduction of nitroacridines by xanthine oxidase and by dihydroflavin mononucleotide. J. Chem Soc. Perkin Trans. II. 951-954.
    • (1991) J. Chem Soc. Perkin Trans. , vol.2 , pp. 951-954
    • Oconnor, C.J.1    Denny, W.A.2    McLennan, D.J.3    Sutton, B.M.4    Wilson, W.R.5
  • 118
    • 0027219332 scopus 로고
    • Bioreducible mustards: A paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs)
    • Denny, W.A. and Wilson, W.R. (1993) Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs). Cancer Metastasis Rev. 12, 135-151.
    • (1993) Cancer Metastasis Rev. , vol.12 , pp. 135-151
    • Denny, W.A.1    Wilson, W.R.2
  • 119
    • 0011942747 scopus 로고
    • Nitroacridines and nitroquinolines as DNA-affinic hypoxia-selective cytotoxins
    • Adams, G.E., Breccia, A., Wardman, P. and Fielden, E.M. (Eds), Activation of Drugs by Redox Processes Plenum Press, New York
    • Denny, W.A., Wilson, W.R., Atwell, G.J., Boyd, M., Pullen, S.M. and Anderson, R.F. (1990) Nitroacridines and nitroquinolines as DNA-affinic hypoxia-selective cytotoxins. In: Adams, G.E., Breccia, A., Wardman, P. and Fielden, E.M. (Eds), Activation of Drugs by Redox Processes (NATO Adv. Study Ser. Vol. 198), Plenum Press, New York, pp. 149-158.
    • (1990) NATO Adv. Study Ser. , vol.198 , pp. 149-158
    • Denny, W.A.1    Wilson, W.R.2    Atwell, G.J.3    Boyd, M.4    Pullen, S.M.5    Anderson, R.F.6
  • 120
    • 0022535929 scopus 로고
    • Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells
    • Denny, W.A. and Wilson, W.R. (1986) Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells. J. Med. Chem. 29, 879-887.
    • (1986) J. Med. Chem. , vol.29 , pp. 879-887
    • Denny, W.A.1    Wilson, W.R.2
  • 121
    • 0001759117 scopus 로고
    • Enzyme inhibition by nitro and nitroso compounds
    • Alston, T.A., Proter, D.J.T. and Bright, H.J. (1983) Enzyme inhibition by nitro and nitroso compounds. Acc. Chem. Res. 16, 418-424.
    • (1983) Acc. Chem. Res. , vol.16 , pp. 418-424
    • Alston, T.A.1    Proter, D.J.T.2    Bright, H.J.3
  • 122
    • 0024501573 scopus 로고
    • Molecular orbital calculations on tumor-inhibitory aniline mustards: QSARs
    • Lewis, D.F.V. (1989) Molecular orbital calculations on tumor-inhibitory aniline mustards: QSARs. Xenobiotica 19, 243-251.
    • (1989) Xenobiotica , vol.19 , pp. 243-251
    • Lewis, D.F.V.1
  • 123
    • 0025021102 scopus 로고
    • Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines
    • Palmer, B.D., Wilson, W.R., Pullen, S.M. and Denny, W.A. (1990) Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. J. Med. Chem. 33, 112-121.
    • (1990) J. Med. Chem. , vol.33 , pp. 112-121
    • Palmer, B.D.1    Wilson, W.R.2    Pullen, S.M.3    Denny, W.A.4
  • 124
    • 0026665360 scopus 로고
    • Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells
    • Palmer, B.D., Wilson, W.R., Cliffe, S. and Denny, W.A. (1992) Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. J. Med. Chem. 35, 3214-3222.
    • (1992) J. Med. Chem. , vol.35 , pp. 3214-3222
    • Palmer, B.D.1    Wilson, W.R.2    Cliffe, S.3    Denny, W.A.4
  • 125
    • 0025951037 scopus 로고
    • Nitroheterocycle reduction as a paradigm for intramolecular catalysis of drug delivery to hypoxic cells
    • Firestone, A., Mulcahy, R.T. and Borch, R.F. (1991) Nitroheterocycle reduction as a paradigm for intramolecular catalysis of drug delivery to hypoxic cells. J. Med. Chem. 34, 2933-2935.
    • (1991) J. Med. Chem. , vol.34 , pp. 2933-2935
    • Firestone, A.1    Mulcahy, R.T.2    Borch, R.F.3
  • 126
    • 0028308246 scopus 로고
    • Nitrobenzyl mustard quaternary salts: A new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction
    • Denny, W.A., Wilson, W.R., Tercel, M., Van Zijl, P. and Pullen, S.M. (1994) Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction. Int. J. Radiat. Oncol. Biol. Phys. 29, 317-321
    • (1994) Int. J. Radiat. Oncol. Biol. Phys. , vol.29 , pp. 317-321
    • Denny, W.A.1    Wilson, W.R.2    Tercel, M.3    Van Zijl, P.4    Pullen, S.M.5
  • 127
    • 0028292905 scopus 로고
    • Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: Potential prodrugs of cyclization-activated aromatic mustards
    • Atwell, G.J., Sykes, B.M., O'Connor, C.J. and Denny, W.A. (1994) Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: potential prodrugs of cyclization-activated aromatic mustards. J. Med. Chem. 37, 371-380.
    • (1994) J. Med. Chem. , vol.37 , pp. 371-380
    • Atwell, G.J.1    Sykes, B.M.2    O'Connor, C.J.3    Denny, W.A.4
  • 128
    • 0021971997 scopus 로고
    • Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro
    • Keyes, S.R., Rockwell, S. and Sartorelli, A.C. (1985) Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res. 45, 3642-3645.
    • (1985) Cancer Res. , vol.45 , pp. 3642-3645
    • Keyes, S.R.1    Rockwell, S.2    Sartorelli, A.C.3
  • 129
    • 0023774903 scopus 로고
    • Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumors by dicoumarol in vitro
    • Rockwell, S., Keyes, S.R. and Sartorelli, A.C. (1988) Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumors by dicoumarol in vitro. Cancer Res. 48, 5471-5474.
    • (1988) Cancer Res. , vol.48 , pp. 5471-5474
    • Rockwell, S.1    Keyes, S.R.2    Sartorelli, A.C.3
  • 130
    • 0025893246 scopus 로고
    • The role of NAD(P)H: Quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9
    • Walton, M.I., Smith, P.J. and Workman, P. (1991) The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun. 3, 199-206.
    • (1991) Cancer Commun. , vol.3 , pp. 199-206
    • Walton, M.I.1    Smith, P.J.2    Workman, P.3
  • 131
    • 0025797202 scopus 로고
    • Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT diaphorase
    • Dulhanty, A.M. and Whitmore, G.F. (1991) Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT diaphorase. Cancer Res. 51, 1860-1865.
    • (1991) Cancer Res. , vol.51 , pp. 1860-1865
    • Dulhanty, A.M.1    Whitmore, G.F.2
  • 132
    • 0001464558 scopus 로고
    • Reductive lactonization of strategically methylated quinone propionic acid esters and amides
    • Carpino, L.A., Triolo, S.A. and Berglund, R.A. (1988) Reductive lactonization of strategically methylated quinone propionic acid esters and amides. J. Org. Chem. 54, 3303-3310.
    • (1988) J. Org. Chem. , vol.54 , pp. 3303-3310
    • Carpino, L.A.1    Triolo, S.A.2    Berglund, R.A.3
  • 133
    • 0015526371 scopus 로고
    • Stereopopulation control. I. Rate enhancement in the lactonizations of o-hydroxyhydrocinnamic acids
    • Milstien, S. and Cohen, L.A. (1972) Stereopopulation control. I. Rate enhancement in the lactonizations of o-hydroxyhydrocinnamic acids. J. Am. Chem. Soc. 94, 9158-9165.
    • (1972) J. Am. Chem. Soc. , vol.94 , pp. 9158-9165
    • Milstien, S.1    Cohen, L.A.2
  • 134
    • 0015526361 scopus 로고
    • Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement
    • Borchardt, R.T. and Cohen, L.A. (1972) Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement. J. Am. Chem. Soc. 94, 9166-9174.
    • (1972) J. Am. Chem. Soc. , vol.94 , pp. 9166-9174
    • Borchardt, R.T.1    Cohen, L.A.2
  • 135
    • 0015526376 scopus 로고
    • Stereopopulation control. III. Facilitation of intramolecular conjugate addition of the carboxyl group
    • Borchardt, R.T. and Cohen, L.A. (1972) Stereopopulation control. III. Facilitation of intramolecular conjugate addition of the carboxyl group. J. Am. Chem. Soc. 94, 9175-9182.
    • (1972) J. Am. Chem. Soc. , vol.94 , pp. 9175-9182
    • Borchardt, R.T.1    Cohen, L.A.2
  • 136
    • 0000160051 scopus 로고
    • Correlation of reaction rate acceleration with rotational restriction. Crystal structure analysis of compounds with a trialkyl lock
    • Karle, J.M. and Karle, I.L. (1972) Correlation of reaction rate acceleration with rotational restriction. Crystal structure analysis of compounds with a trialkyl lock. J. Am. Chem. Soc. 94, 9182-9189.
    • (1972) J. Am. Chem. Soc. , vol.94 , pp. 9182-9189
    • Karle, J.M.1    Karle, I.L.2
  • 137
    • 0000492812 scopus 로고
    • Formation and hydrolysis of lactones of phenolic acids
    • Caswell, M. and Schmir, G.L. (1980) Formation and hydrolysis of lactones of phenolic acids. J. Am. Chem. Soc. 102, 4815-4821.
    • (1980) J. Am. Chem. Soc. , vol.102 , pp. 4815-4821
    • Caswell, M.1    Schmir, G.L.2
  • 138
    • 0025869654 scopus 로고
    • Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug
    • Amsberry, K.L. and Borchardt, R.T. (1991) Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug. Pharm. Res. 8, 323-330.
    • (1991) Pharm. Res. , vol.8 , pp. 323-330
    • Amsberry, K.L.1    Borchardt, R.T.2
  • 139
    • 0027220811 scopus 로고
    • Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: A new class of bioreductive agent
    • Patterson, L.H. (1993) Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent. Cancer Metastasis Rev. 12, 119-134.
    • (1993) Cancer Metastasis Rev. , vol.12 , pp. 119-134
    • Patterson, L.H.1
  • 140
    • 0024427760 scopus 로고
    • Reduction of nitromin to nitrogen mustard: Unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell lines
    • White, I.N.H., Suzanger, M., Mattocks, A.R., Bailey, E., Farmer, P.B., Connors, T.A. (1989) Reduction of nitromin to nitrogen mustard: unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell lines. Carcinogenesis 10, 2113-2118.
    • (1989) Carcinogenesis , vol.10 , pp. 2113-2118
    • White, I.N.H.1    Suzanger, M.2    Mattocks, A.R.3    Bailey, E.4    Farmer, P.B.5    Connors, T.A.6
  • 141
    • 37049083007 scopus 로고
    • Synthesis of novel N-and S-mustards as potential pro-drugs activated by bioreductive processes
    • Mann, J., Shervington, L.A. (1991) Synthesis of novel N-and S-mustards as potential pro-drugs activated by bioreductive processes. J. Chem. Soc. Perkin Trans. I 2961-2964.
    • (1991) J. Chem. Soc. Perkin Trans. , vol.1 , pp. 2961-2964
    • Mann, J.1    Shervington, L.A.2
  • 142
  • 143
    • 0027931173 scopus 로고
    • Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: A direct role for NADPH:Cytochrome P450 oxidoreductase
    • Fitzsimmons, S.A., Lewis, A.D. Riley, R.J. and Workman, P. (1994) Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase. Carcinogenesis 15, 1503-1510.
    • (1994) Carcinogenesis , vol.15 , pp. 1503-1510
    • Fitzsimmons, S.A.1    Lewis, A.D.2    Riley, R.J.3    Workman, P.4
  • 144
    • 0026047102 scopus 로고
    • Microsomal reduction of 3-amino-1,2,4-benzotriazene 1,4-dioxide to a free radical
    • Lloyd, R.V., Duling, D.R., Rumyantseva, G.V., Mason, R.P. and Bridson, P.K. (1991). Microsomal reduction of 3-amino-1,2,4-benzotriazene 1,4-dioxide to a free radical. Mol. Pharmacol. 40, 440-445.
    • (1991) Mol. Pharmacol. , vol.40 , pp. 440-445
    • Lloyd, R.V.1    Duling, D.R.2    Rumyantseva, G.V.3    Mason, R.P.4    Bridson, P.K.5
  • 145
    • 0017282490 scopus 로고
    • Reduction of tertiary amine N-oxids by microsomal cytochrome P450
    • Suguira, M., Iwasaki, K. and Kato, R. (1976) Reduction of tertiary amine N-oxids by microsomal cytochrome P450. Mol. Pharmacol. 12, 322-334.
    • (1976) Mol. Pharmacol. , vol.12 , pp. 322-334
    • Suguira, M.1    Iwasaki, K.2    Kato, R.3
  • 146
    • 0025073825 scopus 로고
    • Reductive metabolism of 3-amino-1,2,4-benzotriazene-1,4-dioxide (SR4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines
    • Cahill, A. and White, I.N.H. (1990) Reductive metabolism of 3-amino-1,2,4-benzotriazene-1,4-dioxide (SR4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines. Carcinogenesis 11, 1407-1411.
    • (1990) Carcinogenesis , vol.11 , pp. 1407-1411
    • Cahill, A.1    White, I.N.H.2
  • 147
    • 0023689603 scopus 로고
    • Metabolism of SR 4233 by Chinese hamster ovary cells: Basis of selective hypoxic cyjtotoxicity
    • Baker, M.A., Zeman, E.M., Hirst, V.K. and Brown. J.M. (1988) Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cyjtotoxicity. Cancer Res. 48, 5947-5952.
    • (1988) Cancer Res. , vol.48 , pp. 5947-5952
    • Baker, M.A.1    Zeman, E.M.2    Hirst, V.K.3    Brown, J.M.4
  • 148
    • 0027418726 scopus 로고
    • Metabolism of the bioreductive cytotoxin SR 4233 by tumor cells: Enzymatic studies
    • Wang, J., Biedermann, K.A., Wolf, C.R. and Brown, J.M. (1993) Metabolism of the bioreductive cytotoxin SR 4233 by tumor cells: enzymatic studies. Br. J. Cancer 67, 321-325.
    • (1993) Br. J. Cancer , vol.67 , pp. 321-325
    • Wang, J.1    Biedermann, K.A.2    Wolf, C.R.3    Brown, J.M.4
  • 149
    • 0024532975 scopus 로고
    • In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazene-1,4-di-oxide), a hypoxic cytotoxin and potential antitumor agent
    • Costa, A.K., Baker, M.A., Brown, J.M. and Truddell, J.R. (1989) In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazene-1,4-di-oxide), a hypoxic cytotoxin and potential antitumor agent. Cancer Res. 49, 925-929.
    • (1989) Cancer Res. , vol.49 , pp. 925-929
    • Costa, A.K.1    Baker, M.A.2    Brown, J.M.3    Truddell, J.R.4
  • 150
    • 0025308187 scopus 로고
    • The effects of three bioreductive drugs (mitomycin C, RSU 1069, and SR 4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation
    • Kohane, A., Godden, J., Stratford, I.J. and Adams, G.E. (1990) The effects of three bioreductive drugs (mitomycin C, RSU 1069, and SR 4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation. Br. J. Cancer 61, 722-726.
    • (1990) Br. J. Cancer , vol.61 , pp. 722-726
    • Kohane, A.1    Godden, J.2    Stratford, I.J.3    Adams, G.E.4
  • 151
    • 0026073332 scopus 로고
    • SR4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures
    • Biederman, K.A., Wang, J. Graham, R.P. and Brown, J.M. (1991) SR4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures. Br. J. Cancer 63, 358-362.
    • (1991) Br. J. Cancer , vol.63 , pp. 358-362
    • Biederman, K.A.1    Wang, J.2    Graham, R.P.3    Brown, J.M.4
  • 152
    • 0024414046 scopus 로고
    • The differntial hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay
    • Stratford, I.J. and Stephens, M.A. (1989) The differntial hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. Int. J. Radiat. Oncol. Biol. Phys. 16, 973-976.
    • (1989) Int. J. Radiat. Oncol. Biol. Phys. , vol.16 , pp. 973-976
    • Stratford, I.J.1    Stephens, M.A.2
  • 155
    • 0018250764 scopus 로고
    • Drug latentiation in cancer chemotherapy
    • Workman and Double, J.A. (1978) Drug latentiation in cancer chemotherapy. Biomedicine 28, 2555-2562.
    • (1978) Biomedicine , vol.28 , pp. 2555-2562
    • Workman1    Double, J.A.2
  • 157
    • 0017845325 scopus 로고
    • Inhibition of human prostatic tumor acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards
    • Workman, P. (1978) Inhibition of human prostatic tumor acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards. Chem-Biol. Interact. 20, 103-112.
    • (1978) Chem-Biol. Interact. , vol.20 , pp. 103-112
    • Workman, P.1
  • 159
    • 0019860703 scopus 로고
    • An examination of the relative resistances to aflatoxin B1 and susceptibilities to gamma-glutamyltransferase negative and positive cell lines
    • Manson M.M., Legg R.F., Watson J.V., Green J.A. and Neal G.E. (1981) An examination of the relative resistances to aflatoxin B1 and susceptibilities to gamma-glutamyltransferase negative and positive cell lines. Carcinogenesis 2, 661-670.
    • (1981) Carcinogenesis , vol.2 , pp. 661-670
    • Manson, M.M.1    Legg, R.F.2    Watson, J.V.3    Green, J.A.4    Neal, G.E.5
  • 160
    • 0022576114 scopus 로고
    • Prodrugs in cancer chemotherapy
    • Wilman, D.E.V. (1986) Prodrugs in cancer chemotherapy. Biochem. Soc. Trans. 14, 375-382.
    • (1986) Biochem. Soc. Trans. , vol.14 , pp. 375-382
    • Wilman, D.E.V.1
  • 161
    • 0014024073 scopus 로고
    • Cure of mice bearng advanced plasma cell tumours with aniline mustard: The relationship between glucuronidase activity and tumour sensitivity
    • Connors, T.A. and Whisson, M.E. (1966) Cure of mice bearng advanced plasma cell tumours with aniline mustard: The relationship between glucuronidase activity and tumour sensitivity. Nature 210, 866-867.
    • (1966) Nature , vol.210 , pp. 866-867
    • Connors, T.A.1    Whisson, M.E.2
  • 162
    • 0002377785 scopus 로고
    • Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system
    • Ross, W. C. J. and Warwick, G. P. (1955) Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system. Nature 176, 298-299.
    • (1955) Nature , vol.176 , pp. 298-299
    • Ross, W.C.J.1    Warwick, G.P.2
  • 163
    • 0142192711 scopus 로고
    • Aryl-2-halogenoalkylamines. Part XVI. The preparation of 4-[di-(2-chloroalkyl)amino]azobenzenes
    • Ross, W.C.J. and Warwick, G. P. (1956) Aryl-2-halogenoalkylamines. Part XVI. The preparation of 4-[di-(2-chloroalkyl)amino]azobenzenes. J. Chem. Soc. 1364-1369.
    • (1956) J. Chem. Soc. , pp. 1364-1369
    • Ross, W.C.J.1    Warwick, G.P.2
  • 167
    • 0015867805 scopus 로고
    • High-dose diethylstilbesterol therapy of prostate cancer after failure of standard doses of oestrogens
    • Band, P.R., Banerjee, T.K., Patwardhan, V.C. and Eid, J.C. (1973) High-dose diethylstilbesterol therapy of prostate cancer after failure of standard doses of oestrogens. Cancer Med. Assoc. J. 109, 697-699.
    • (1973) Cancer Med. Assoc. J. , vol.109 , pp. 697-699
    • Band, P.R.1    Banerjee, T.K.2    Patwardhan, V.C.3    Eid, J.C.4
  • 168
    • 0016432718 scopus 로고
    • Oral estramustine phosphate (NSX-89199) in the treatment of advanced (stage D) carcinoma of the prostate
    • Mittleman, A., Shukla, S.K., Welwaart, K. and Murphy, G.P. (1975) Oral estramustine phosphate (NSX-89199) in the treatment of advanced (stage D) carcinoma of the prostate. Cancer Chemother. Rep. 59, 219-223.
    • (1975) Cancer Chemother. Rep. , vol.59 , pp. 219-223
    • Mittleman, A.1    Shukla, S.K.2    Welwaart, K.3    Murphy, G.P.4
  • 169
    • 0017397510 scopus 로고
    • A new high-glucuronidase mouse tumour curable by aniline mustard therapy
    • Double, J.A. and Workman, P.A. (1977) A new high-glucuronidase mouse tumour curable by aniline mustard therapy. Cancer Treat. Rep. 61, 909-911.
    • (1977) Cancer Treat. Rep. , vol.61 , pp. 909-911
    • Double, J.A.1    Workman, P.A.2
  • 171
    • 0017167325 scopus 로고
    • Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β-glucuronidase activity
    • Young, C.W., Yogoda, A., Bitlar, E.S., Smith, S.W., Grabstald, H. and Whitmore, W. (1976) Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β-glucuronidase activity. Cancer 38, 1887-1895.
    • (1976) Cancer , vol.38 , pp. 1887-1895
    • Young, C.W.1    Yogoda, A.2    Bitlar, E.S.3    Smith, S.W.4    Grabstald, H.5    Whitmore, W.6
  • 172
    • 0017604857 scopus 로고
    • Gamma-glutamyltransferase levels in ascitic fluid and liver tissue from patients with primary hepatoma
    • Peters, T.J., Seymour, C.A., Wells, G., Fakunle, F. and Neale, G. (1977) Gamma-glutamyltransferase levels in ascitic fluid and liver tissue from patients with primary hepatoma. Br. Med. J. Part I, 1576.
    • (1977) Br. Med. J. Part I , pp. 1576
    • Peters, T.J.1    Seymour, C.A.2    Wells, G.3    Fakunle, F.4    Neale, G.5
  • 173
    • 0028174228 scopus 로고
    • γ-Glutamyltranspeptidase expression regulates the growth-inhibitory activity of the anti-tumor prodrug γ-L-glutaminyl-4-hydroxy-3-iodobenzene
    • Prezioso, J.A., Hughey, R.P., Wang, N., Damodaran, K.M. and Bloomer, W.D. (1994) γ-Glutamyltranspeptidase expression regulates the growth-inhibitory activity of the anti-tumor prodrug γ-L-glutaminyl-4-hydroxy-3-iodobenzene. Int. J. Cancer 56, 874-879.
    • (1994) Int. J. Cancer , vol.56 , pp. 874-879
    • Prezioso, J.A.1    Hughey, R.P.2    Wang, N.3    Damodaran, K.M.4    Bloomer, W.D.5
  • 174
    • 0020607978 scopus 로고
    • Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard
    • Chakravarty, P.K., Carl, P.L., Weber, M.J. and Katzenellenbogen, J.A. (1983) Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard. J. Med. Chem. 26. 633-638.
    • (1983) J. Med. Chem. , vol.26 , pp. 633-638
    • Chakravarty, P.K.1    Carl, P.L.2    Weber, M.J.3    Katzenellenbogen, J.A.4
  • 175
    • 0020644940 scopus 로고
    • Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin
    • Chakravarty, P.K., Carl, P.L., Weber, M.J. and Katzenellenbogen, J.A. (1983) Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin. J. Med. Chem. 26, 638-644.
    • (1983) J. Med. Chem. , vol.26 , pp. 638-644
    • Chakravarty, P.K.1    Carl, P.L.2    Weber, M.J.3    Katzenellenbogen, J.A.4
  • 176
    • 0014007589 scopus 로고
    • pH studies in human malignant tumours
    • Ashby, B.S. (1966) pH studies in human malignant tumours. Lancet 2, 312-315.
    • (1966) Lancet , vol.2 , pp. 312-315
    • Ashby, B.S.1
  • 177
    • 0343749880 scopus 로고
    • Experimental studies on cancer. I. The influence of patenteral administration of certain sugars on the pH of malignant tumours
    • Voegtlin, C., Fitch, R.H., Kahler, H., Johnson, J.M. and Thomson, J.W. (1935) Experimental studies on cancer. I. The influence of patenteral administration of certain sugars on the pH of malignant tumours. Natl. Inst. Health Bull. 164, 1-14.
    • (1935) Natl. Inst. Health Bull. , vol.164 , pp. 1-14
    • Voegtlin, C.1    Fitch, R.H.2    Kahler, H.3    Johnson, J.M.4    Thomson, J.W.5
  • 178
    • 0014098952 scopus 로고
    • Glucose consumption by transplanted tumors in vivo
    • Gullino, P.M., Grantham, F.H. and Courtney, A.H. (1967) Glucose consumption by transplanted tumors in vivo. Cancer Res. 27, 1031-1040.
    • (1967) Cancer Res. , vol.27 , pp. 1031-1040
    • Gullino, P.M.1    Grantham, F.H.2    Courtney, A.H.3
  • 179
    • 0020030456 scopus 로고
    • Tumor-selective modification of cellular microenvironment in vivo: Effect of glucose infusion on the pH in normal and malignant rat tissues
    • Jahde, E. and Rajewsky, M.F. (1982) Tumor-selective modification of cellular microenvironment in vivo: effect of glucose infusion on the pH in normal and malignant rat tissues. Cancer Res. 42, 1505-1512.
    • (1982) Cancer Res. , vol.42 , pp. 1505-1512
    • Jahde, E.1    Rajewsky, M.F.2
  • 180
    • 77956791953 scopus 로고
    • Taxol: From discovery to therapeutic use
    • Suffness, M. (1993) Taxol: from discovery to therapeutic use. Ann. Rep. Med. Chem. 28, 305-314.
    • (1993) Ann. Rep. Med. Chem. , vol.28 , pp. 305-314
    • Suffness, M.1
  • 181
    • 0024597827 scopus 로고
    • Synthesis of congeners and prodrugs, 3. Water-soluble prodrugs of taxol with potent antitumor activity
    • Deutsch, H.M., Hernandez, M., Haugwitz, R.D., Narayanan, V.L., Suffness, M. and Zalkow, L.H. (1989) Synthesis of congeners and prodrugs, 3. Water-soluble prodrugs of taxol with potent antitumor activity. J. Med. Chem. 32, 788-792.
    • (1989) J. Med. Chem. , vol.32 , pp. 788-792
    • Deutsch, H.M.1    Hernandez, M.2    Haugwitz, R.D.3    Narayanan, V.L.4    Suffness, M.5    Zalkow, L.H.6
  • 182
    • 0026317822 scopus 로고
    • Modified taxols, 6. Preparation of water-soluble prodrugs of taxol
    • Zhao, Z. and Kingston, D.G.I. (1991) Modified taxols, 6. preparation of water-soluble prodrugs of taxol. J. Natural Prod. 54, 1607-1611.
    • (1991) J. Natural Prod. , vol.54 , pp. 1607-1611
    • Zhao, Z.1    Kingston, D.G.I.2
  • 183
    • 0026567883 scopus 로고
    • Synthesis and evaluation of some water soluble prodrugs and derivatives of taxol with antitumor activity
    • Mathew, A.E., Mejillano, M.R., Nath, J.P., Himes, R.H. and Stella, V.J. (1992) Synthesis and evaluation of some water soluble prodrugs and derivatives of taxol with antitumor activity. J. Med. Chem. 35, 145-151.
    • (1992) J. Med. Chem. , vol.35 , pp. 145-151
    • Mathew, A.E.1    Mejillano, M.R.2    Nath, J.P.3    Himes, R.H.4    Stella, V.J.5
  • 184
  • 185
    • 0028062072 scopus 로고
    • Highly water soluble taxol derivatives: 2-polyethyleneglycol esters as potential prodrugs
    • Greenwald, R.B., Pendri, A., Bolikal, D. and Gilbert, C.W. (1994) Highly water soluble taxol derivatives: 2-polyethyleneglycol esters as potential prodrugs. Bioorg. Med. Chem. Lett. 4, 2465-2470.
    • (1994) Bioorg. Med. Chem. Lett. , vol.4 , pp. 2465-2470
    • Greenwald, R.B.1    Pendri, A.2    Bolikal, D.3    Gilbert, C.W.4
  • 194
    • 0028115928 scopus 로고
    • Dose-dependent pharmacokinetics of rapamycin-28-N,N-dimethylglycinate in the mouse
    • Supko, J.G. and Malspeis, L. (1994) Dose-dependent pharmacokinetics of rapamycin-28-N,N-dimethylglycinate in the mouse. Cancer Chemother. Pharmacol. 33, 325-330.
    • (1994) Cancer Chemother. Pharmacol. , vol.33 , pp. 325-330
    • Supko, J.G.1    Malspeis, L.2
  • 195
    • 0027172492 scopus 로고
    • N-Phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity
    • Murdock, K.C., Lee, V.J., Citarella, R.V., Durr, F.E., Nicolau, G. and Kohlbrenner, M. (1993) N-Phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity. J. Med. Chem. 36, 2098-2101.
    • (1993) J. Med. Chem. , vol.36 , pp. 2098-2101
    • Murdock, K.C.1    Lee, V.J.2    Citarella, R.V.3    Durr, F.E.4    Nicolau, G.5    Kohlbrenner, M.6
  • 196
    • 0022626910 scopus 로고
    • Blood-brain barrier: Interface between medicine and the brain
    • Pardridge, W.M., Oldendorf, W., Cancilla, P. and Frank, H. (1986) Blood-brain barrier: interface between medicine and the brain. Ann. Int. Med. 105, 82-95.
    • (1986) Ann. Int. Med. , vol.105 , pp. 82-95
    • Pardridge, W.M.1    Oldendorf, W.2    Cancilla, P.3    Frank, H.4
  • 198
    • 0011229610 scopus 로고
    • The blood-brain barrier. A modified tight epithelium
    • Suckling, A.J., Rumsby, M.G. and Bradbury, M.W.B. (Eds), Ellis Harwood, Chichester, UK
    • Crone, C. (1986) The blood-brain barrier. A modified tight epithelium. In: Suckling, A.J., Rumsby, M.G. and Bradbury, M.W.B. (Eds), The Blood-Brain Barrier in Health and Disease. Ellis Harwood, Chichester, UK.
    • (1986) The Blood-brain Barrier in Health and Disease
    • Crone, C.1
  • 199
    • 0021800252 scopus 로고
    • Prodrugs, do they have advantages in clinical practice?
    • Stella, V.J., Charman, W.N.A. and Naringrekar, V.H. (1985) Prodrugs, do they have advantages in clinical practice? Drugs 29, 455-473.
    • (1985) Drugs , vol.29 , pp. 455-473
    • Stella, V.J.1    Charman, W.N.A.2    Naringrekar, V.H.3
  • 200
    • 0000120844 scopus 로고
    • Novel approaches to the design of safer drugs: Soft drugs and site-specific chemical delivery systems
    • Bodor, N. (1984) Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systems. Adv. Drug Res. 13, 225-331.
    • (1984) Adv. Drug Res. , vol.13 , pp. 225-331
    • Bodor, N.1
  • 201
    • 0342444609 scopus 로고
    • In vivo elimination of dihydropyridine drug carriers from brain and blood of rats
    • Bodor, N., El-Kommos, M.E. and Nath, C. (1986) In vivo elimination of dihydropyridine drug carriers from brain and blood of rats. Bull. Pharm. Sci. Assiut Univ. 9, 14-29.
    • (1986) Bull. Pharm. Sci. Assiut Univ. , vol.9 , pp. 14-29
    • Bodor, N.1    El-Kommos, M.E.2    Nath, C.3
  • 202
    • 0019843193 scopus 로고
    • Site-specific, sustained release of drugs to the brain
    • Bodor, N., Farag, H. and Brewster, M. (1981) Site-specific, sustained release of drugs to the brain. Science 214, 1370-1372.
    • (1981) Science , vol.214 , pp. 1370-1372
    • Bodor, N.1    Farag, H.2    Brewster, M.3
  • 203
    • 0024337493 scopus 로고
    • Improved delivery through biological membranes. XL1. Brain-enhanced delivery of chlorambucil
    • Bodor, N., Vasudevan, V.D.W., Estes, K. and Brewster, M.E. (1989) Improved delivery through biological membranes. XL1. Brain-enhanced delivery of chlorambucil. Int. J. Pharmacol. 53, 195-208.
    • (1989) Int. J. Pharmacol. , vol.53 , pp. 195-208
    • Bodor, N.1    Vasudevan, V.D.W.2    Estes, K.3    Brewster, M.E.4
  • 204
    • 0027007974 scopus 로고
    • Redox approaches to drug delivery to the central nervous system
    • Frankenheim, J. and Brown, R.M. (Eds), US Department of Health and Human Services, Rockville, MD
    • Brewster, M.E. and Bodor, N.(1992) Redox approaches to drug delivery to the central nervous system. In: Frankenheim, J. and Brown, R.M. (Eds), Bioavailability of Drugs to the Brain and the Blood-Brain Barrier, US Department of Health and Human Services, Rockville, MD, pp. 169-201.
    • (1992) Bioavailability of Drugs to the Brain and the Blood-brain Barrier , pp. 169-201
    • Brewster, M.E.1    Bodor, N.2
  • 206
    • 0028339741 scopus 로고
    • Tributyrin: A prodrug of butyric acid for potential clinical application in differentiation therapy
    • Chen, Z.-X. and Breitman, T.R. (1994) Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res. 54, 3494-3499.
    • (1994) Cancer Res. , vol.54 , pp. 3494-3499
    • Chen, Z.-X.1    Breitman, T.R.2
  • 207
    • 0027316830 scopus 로고
    • Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug
    • Rabizadeh, E., Shaklai, M., Nudelman, A., Eisenbach, L. and Rephaeli, A. (1993) Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEBS Lett. 328, 225-229.
    • (1993) FEBS Lett. , vol.328 , pp. 225-229
    • Rabizadeh, E.1    Shaklai, M.2    Nudelman, A.3    Eisenbach, L.4    Rephaeli, A.5
  • 208
    • 0028219470 scopus 로고
    • Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an hl-60 leukemic cell line
    • Aviram, A., Zimrah, Y., Shaklai, M., Nudelman, A. and Rephaeli, A. (1994) Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an hl-60 leukemic cell line. Int. J. Cancer 56, 906-909.
    • (1994) Int. J. Cancer , vol.56 , pp. 906-909
    • Aviram, A.1    Zimrah, Y.2    Shaklai, M.3    Nudelman, A.4    Rephaeli, A.5
  • 209
    • 0342444597 scopus 로고
    • Triazenylimidazoles, other triazenes, and imidazolo[5,1-d]-1,2,3,5-tetrazine-4(3H)-ones
    • Foye, W.O. (Ed.), American Chemical Society, Washington, DC
    • Shealy, Y.F. (1995) Triazenylimidazoles, other triazenes, and imidazolo[5,1-d]-1,2,3,5-tetrazine-4(3H)-ones. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 159-186.
    • (1995) Cancer Chemotherapeutic Agents , pp. 159-186
    • Shealy, Y.F.1
  • 210
    • 0002658038 scopus 로고
    • Nitrogen mustard and related structures
    • Foye, W.O. (Ed.), American Chemical Society, Washington, DC
    • Struck, R.F., (1995) Nitrogen mustard and related structures. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 112-121.
    • (1995) Cancer Chemotherapeutic Agents , pp. 112-121
    • Struck, R.F.1
  • 211
    • 0028177704 scopus 로고
    • Chemoprotection against cyclophosphamide-induced urotoxicity: Comparison of nine thiol protective agents
    • and references cited therein
    • Roberts, J.C., Franatio, D.J. and Zera, R.T. (1994) Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents. Anticancer Res. 14, 389-396, and references cited therein.
    • (1994) Anticancer Res. , vol.14 , pp. 389-396
    • Roberts, J.C.1    Franatio, D.J.2    Zera, R.T.3
  • 213
    • 0024334082 scopus 로고
    • Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: A strategy for tumor-selective activation of cytocidal drugs
    • Tietze, L.F., Neumann, M., Mollers, T., Fischer, R., Glusenkamp, K.-H., Rajewsky, M.F. and Jahde, E. (1989) Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocidal drugs. Cancer Res. 49, 4179-4184.
    • (1989) Cancer Res. , vol.49 , pp. 4179-4184
    • Tietze, L.F.1    Neumann, M.2    Mollers, T.3    Fischer, R.4    Glusenkamp, K.-H.5    Rajewsky, M.F.6    Jahde, E.7
  • 214
    • 0342444586 scopus 로고
    • Novel stable bioactivated cyclophosphamide derivatives for selective cancer chemotherapy, synthesis of aldophosphamide acetal-glycosides and their glycoconjugates
    • Tietze, L.F., Fischer, R., Beller, M. and Seele, R. (1990) Novel stable bioactivated cyclophosphamide derivatives for selective cancer chemotherapy, synthesis of aldophosphamide acetal-glycosides and their glycoconjugates. Liebigs Ann. Chem. 151-157.
    • (1990) Liebigs Ann. Chem. , pp. 151-157
    • Tietze, L.F.1    Fischer, R.2    Beller, M.3    Seele, R.4
  • 215
    • 0021646134 scopus 로고
    • The pharmacology of prodrugs of 5-fluorouracil and 1-β-D-arabinofuranosylcytosine
    • Hadfield, A.F. and Sartorelli, A.C. (1984) The pharmacology of prodrugs of 5-fluorouracil and 1-β-D-arabinofuranosylcytosine. Adv. Pharmacol. Chemother. 20, 21-67.
    • (1984) Adv. Pharmacol. Chemother. , vol.20 , pp. 21-67
    • Hadfield, A.F.1    Sartorelli, A.C.2
  • 216
    • 0000663450 scopus 로고
    • Decreased toxicity and adverse reactions via prodrugs
    • Bundgaard, H. (Ed.), Elsevier, Amsterdam
    • Jones, G. (1985) Decreased toxicity and adverse reactions via prodrugs. In: Bundgaard, H. (Ed.), Design of Prodrugs, Elsevier, Amsterdam, pp. 199-241.
    • (1985) Design of Prodrugs , pp. 199-241
    • Jones, G.1
  • 217
    • 0028347566 scopus 로고
    • Prodrugs of Ara-C
    • Wipf, P. and Li, W. (1994) Prodrugs of Ara-C. Drugs Future 19, 49-54.
    • (1994) Drugs Future , vol.19 , pp. 49-54
    • Wipf, P.1    Li, W.2
  • 218
    • 0342444587 scopus 로고
    • Fluoropyrimidines
    • Foye, W.O. (Ed.), American Chemical Society, Washington, DC
    • Anantham, S. (1995) Fluoropyrimidines. In: Foye, W.O. (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, pp. 49-58.
    • (1995) Cancer Chemotherapeutic Agents , pp. 49-58
    • Anantham, S.1
  • 219
    • 0342444585 scopus 로고
    • Overview of new anticancer drugs developed in Japan
    • Kimura, K., Ota, K., Carter, S.K. and Friedmann T. (Eds), Excerpta Medica, Amsterdam
    • Ariyoshi, Y. (1994) Overview of new anticancer drugs developed in Japan. In: Kimura, K., Ota, K., Carter, S.K. and Friedmann T. (Eds), Cancer Chemotherapy: Challenges for the Future, Excerpta Medica, Amsterdam, pp. 157-217.
    • (1994) Cancer Chemotherapy: Challenges for the Future , pp. 157-217
    • Ariyoshi, Y.1
  • 220
    • 0018869414 scopus 로고
    • Activation of Ftorafur [R,5-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and γ-butyrolactone
    • and references cited therein
    • Au, J.L-S. and Sadee, W. (1980) Activation of Ftorafur [R,5-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and γ-butyrolactone. Cancer Res. 40, 2814-2819, and references cited therein.
    • (1980) Cancer Res. , vol.40 , pp. 2814-2819
    • Au, J.L.-S.1    Sadee, W.2
  • 221
    • 0019287522 scopus 로고
    • Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion
    • Masquelier, M., Baurain, R. and Trouet, A. (1980) Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion. J. Med. Chem. 23, 1166-1170.
    • (1980) J. Med. Chem. , vol.23 , pp. 1166-1170
    • Masquelier, M.1    Baurain, R.2    Trouet, A.3
  • 222
    • 0019301927 scopus 로고
    • Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo
    • Baurain, R., Masquelier, M., Deprez-de Campeneere, D. and Trouet, A. (1980) Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo. J. Med. Chem. 23, 1171-1174.
    • (1980) J. Med. Chem. , vol.23 , pp. 1171-1174
    • Baurain, R.1    Masquelier, M.2    Deprez-De Campeneere, D.3    Trouet, A.4
  • 223
    • 0027050399 scopus 로고
    • The anti-tumour effects of the prodrugs n-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts
    • Boven, E., Hendriks, H.R., Erkelens, C.A.M. and Pinedo, H.M. (1992) The anti-tumour effects of the prodrugs n-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts. Br. J. Cancer 66, 1044-1047.
    • (1992) Br. J. Cancer , vol.66 , pp. 1044-1047
    • Boven, E.1    Hendriks, H.R.2    Erkelens, C.A.M.3    Pinedo, H.M.4
  • 224
    • 0027318628 scopus 로고
    • Aspects of the cellular pharmacology of N-l-leucyldoxorubicin in human tumor cell lines
    • Bennis, S., Garcia, C. and Robert, J. (1993) Aspects of the cellular pharmacology of N-l-leucyldoxorubicin in human tumor cell lines. Biochem. Pharmacol. 45, 1929-1931.
    • (1993) Biochem. Pharmacol. , vol.45 , pp. 1929-1931
    • Bennis, S.1    Garcia, C.2    Robert, J.3
  • 225
    • 0026755410 scopus 로고
    • Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolites inplasma using HPLC with fluorescence detection
    • Jong, J.D., Vermerken, J.B. and Van Der Vijgh, W.J.F. (1992) Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolites inplasma using HPLC with fluorescence detection. J. Pharm. Biomed. Anal. 10, 309-314.
    • (1992) J. Pharm. Biomed. Anal. , vol.10 , pp. 309-314
    • Jong, J.D.1    Vermerken, J.B.2    Van Der Vijgh, W.J.F.3
  • 227
    • 0027052703 scopus 로고
    • Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial
    • de Jong, J., Geijssen, G.J., Munniksma, C.N., Vermorken, J.B. and Van der Vijgh, W.J.F. (1992) Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial. J. Clin. Oncol. 10, 1897-1906.
    • (1992) J. Clin. Oncol. , vol.10 , pp. 1897-1906
    • De Jong, J.1    Geijssen, G.J.2    Munniksma, C.N.3    Vermorken, J.B.4    Van Der Vijgh, W.J.F.5
  • 228
  • 229
    • 0027933231 scopus 로고
    • Pharmacokinetics, tissue distribution, and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to dogs. A new adriamycin analog containing fluorine
    • Yoon, E.J., Lee, E.D., Yoon, W.H., Shim, H.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1994) Pharmacokinetics, tissue distribution, and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to dogs. A new adriamycin analog containing fluorine. Int. J. Pharm. 109, 181-187.
    • (1994) Int. J. Pharm. , vol.109 , pp. 181-187
    • Yoon, E.J.1    Lee, E.D.2    Yoon, W.H.3    Shim, H.J.4    Lee, S.D.5    Kim, W.B.6    Yang, J.7    Lee, M.G.8
  • 230
    • 0028082358 scopus 로고
    • Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to rats. A new adriamycin analog containing fluorine
    • Shim, H.J., Lee, E.D., Yoon, E.J., Lee, S.D., Kim, W.B., Yang, J. and Lee, M.G. (1994) Pharmacokinetics of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to rats. A new adriamycin analog containing fluorine. Int. J. Pharm. 103, 147-154.
    • (1994) Int. J. Pharm. , vol.103 , pp. 147-154
    • Shim, H.J.1    Lee, E.D.2    Yoon, E.J.3    Lee, S.D.4    Kim, W.B.5    Yang, J.6    Lee, M.G.7
  • 232
    • 0003041822 scopus 로고
    • Lipophilic prodrugs and the promotion of intestinal lymphatic drug transport
    • Charman, W.N. and Stella, V.J. (Eds), CRC Press, Boca Raton, FL
    • Stella, V.J. and Pochopin, N.L. (1992) Lipophilic prodrugs and the promotion of intestinal lymphatic drug transport. In: Charman, W.N. and Stella, V.J. (Eds), Lymphatic Transport of Drugs, CRC Press, Boca Raton, FL, pp. 181-210.
    • (1992) Lymphatic Transport of Drugs , pp. 181-210
    • Stella, V.J.1    Pochopin, N.L.2
  • 233
    • 0014575950 scopus 로고
    • The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems
    • Wall, M.F., Abernathy, G.S., Carroll, F.L. and Taylor, D.J. (1969) The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems. J. Med. Chem. 12, 810-818.
    • (1969) J. Med. Chem. , vol.12 , pp. 810-818
    • Wall, M.F.1    Abernathy, G.S.2    Carroll, F.L.3    Taylor, D.J.4
  • 234
    • 0020556575 scopus 로고
    • 1,3-Dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent
    • Garzon-Aburbeh, A., Pouapaert, J.H., Claesen, M., Dumont, P. and Atassi, G. (1983) 1,3-Dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent. J. Med. Chem. 26, 1200-1203.
    • (1983) J. Med. Chem. , vol.26 , pp. 1200-1203
    • Garzon-Aburbeh, A.1    Pouapaert, J.H.2    Claesen, M.3    Dumont, P.4    Atassi, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.